Rushford Switzerland offers one of the most comprehensive MBA programs in Clinical Research in collaboration with the School of Health Sciences at James Lind Institute. This program places emphasis on hands-on aspects of the management of clinical trials. Clinical research is a global phenomenon with almost all countries participating in clinical trials. Stakeholders in clinical trials range from academia, research institutions, industry, governments, patients and caregivers, payers, healthcare organizations, and physicians to name a few.
The regulatory agencies in most markets have been increasingly demanding more concrete safety and efficacy evidence in support of new drug approvals. With the development of more modern study designs and the utilization of techniques such as adaptive study designs, modelling, and simulation, clinical trials are becoming increasingly sophisticated. Newer regulations and guidelines are being applied which necessitates that clinical research professionals stay current on these advances in knowledge and understanding of how to implement clinical trials.
The MBA in Clinical Research program at Rushford is suited to aspirants as well as clinical research professionals of varying experience. Students who complete this program are expected to have advanced knowledge of all the fundamental concepts of clinical trial design and implementation, operational aspects of clinical trials, project management, financial aspects of clinical research, international regulatory affairs, and other aspects of clinical trial management.
Rushford offers Recognition of Prior Experience (RPE) and thus a formal bachelor’s degree is not mandatory for entering this program.
The industry dealing in pharmaceutical and biotech solutions is undergoing quite a bit of change all over the world, as there is an increasing focus on innovation and personalized medicine. Nearly all of the business models are reaching a stage, where the coexistence of novel and old strategies is made possible. Since there are notable improvements in the emerging economies of countries such as India, China, Brazil, and Russia, the industry is gradually fixating research and development in these regions, especially when it comes to clinical development phases. The pharmaceutical and biotech companies in these areas are placing their Research and Development activities in both the innovative molecules and the generic market.
Naturally, this scenario has resulted in the emergence of a number of clinical research management organizations such as full-service CROs, early phase CROs, SMOs, companies with specialized services, etc. This has led to an increased demand for specialists in this sector, which has been clear in recent reports.
EduQua Certified Swiss Institution
Rushford Business School through its parent school (James Lind Institute) is certified by EduQua, a Swiss quality label for further education institutions. EduQua is an accreditation body recognized and supported by the Swiss Confederate Government.
EduQua is the first quality certification for public and private educational institutions in Switzerland and is recognized, supported, and endorsed by the following organizations:
Swiss Federal Government
Swiss Conference of Cantonal Ministers of Education (EDK)
State Secretariat for Economic Affairs (SECO)
Swiss Conference for Professional Training department (SBBK)
Swiss Association of Employment Departments (VSAA)
Swiss Federation for Adult Learning (SVEB)
Accreditation Council for Business Schools and Programs
Rushford Business School through its parent school (James Lind Institute) is a member of the “Accreditation Council for Business Schools and Programs (ACBSP)
ACBSP is the only global accrediting body, which accredits business programs at the associate, baccalaureate, and graduate degree levels worldwide since 1988. Rushford Business School is part of a membership that extends to more than 60 countries. ACBSP members are amongst the best educators in their respective fields, interested in learning innovative teaching methods, improving the delivery of business education programs, and creative value for their students.
Swiss Higher Educational Institution
James Lind Institute is an approved post-secondary higher educational Institution with the authority to award private degrees in Switzerland. The institute is registered in the Canton of Geneva, Switzerland under the UID CHE-255.747.977.
International Council For Open & Distance Education (ICDE), Norway
James Lind Institute is a proud member of the prestigious International Council for Open & Distance Education. ICDE has consultative partner status with UNESCO and shares UNESCO’s key value – the universal right to education for all. ICDE further derives its position from the unique knowledge and experience of its members throughout the world in the development and use of new methodologies and emerging technologies.
International Organization For Standardization (ISO) 9001:2015 Certified
James Lind Institute (JLI) is fully accredited by the AMERICAN BOARD OF ACCREDITATION SERVICES (ABAS) as per ISO 9001:2015 standards for providing Training & Education Programs related to healthcare and allied sectors.